Middle-East & Africa Ophthalmology Therapeutics Market was worth $2.45 billion in 2016 and estimated to grow at a CAGR of 8.1%, to reach $3.62 billion by 2021. Ophthalmology is the science associated with the treatment of eye defects and diseases. Recent advancements in genetics and stem cell biology are progressively boosting the potential for ophthalmology therapeutics.
Browse market data tables and in-depth TOC of the Middle-East & Africa Ophthalmology Therapeutics Market to 2021 @ http://www.marketdataforecast.com/market-reports/middle-east-and-africa-ophthalmology-therapeutics-market-1111/
Middle-East & Africa market for Ophthalmology Therapeutics is driven by the growing prevalence for vision impairment. Advancements in the field of medicine is also a key factor driving the growth of the market. Increasing geriatric population around the region along with an increase in the disposable income of the people are some of the other driving factors for the Ophthalmology Therapeutics Market. However, limited awareness about the diseases associated with ophthalmology is the key restraint for the growth of the market. Uncertain reimbursement policies and stringent regulatory framework are some of the other factors restraining the growth of the market.
Middle-East & Africa Ophthalmology Therapeutics market is broadly categorized into Indication and End User. Based on indication Middle-East & Africa Ophthalmology Therapeutics market is segmented into Glaucoma, Dry Eye Syndrome, Diabetic Retinopathy, Retinal Vein Occlusion, Age-related Macular Degeneration, Macular Edema and Allergic Conjunctivitis. Glaucoma is the largest indication segment accounting for a share of approximately XX% followed by AMD with a share of XX%. On the basis of end user, the market is segmented into Hospitals, Eye Clinics, Diagnostic Centres and Patients. Hospitals account for the largest share of the market with a percentage share of approximately XX% while Diagnostics Centres is the fastest growing segment with a CAGR of XX%.
Free sample of the report is available @ http://www.marketdataforecast.com/market-reports/middle-east-and-africa-ophthalmology-therapeutics-market-1111/request-sample
Based on geography, Middle-East & Africa Ophthalmology Therapeutics market is segmented into Middle-East and Africa. Middle-East is the largest market for Ophthalmology Therapeutics due to high disposable income of the people. Africa is estimated to be the fastest growing region with a CAGR of xx% during the forecast period of 2016-2021.
Some of the major companies covered in the report are Pfizer Inc., Allergan Inc., Alcon Inc., Merck & co. Inc., Roche, Valeant, Regeneron, Santen, Bayer, Senju, Lpath and Eye Gate Pharmaceuticals
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and skillset dedicatedly serve clients from various industries and regions.
Sales Manager (International Business Development)
Market Data Forecast
Direct Line: +1-888-702-9626
Mobile: +91 998 555 0206
Visit MarketDataForecast Blog @ http://www.marketdataforecast.com/blog/
View latest Press Releases of MDF @ http://www.marketdataforecast.com/press-releases